Press release
United States Antibody Drug Conjugates Market to Reach USD 30.42 Billion by 2033, Driven by Targeted Cancer Therapy and Pipeline Expansion | DataM Intelligence
Antibody Drug Conjugates Market
United States: Recent Industry Developments
✅ In October 2025, AstraZeneca received FDA accelerated approval for its novel ADC targeting solid tumours with an improved therapeutic index.
✅ In October 2025, the National Cancer Institute launched a $500 million initiative to advance next-generation ADC technologies.
✅ In October 2025, A major US cancer centre reported breakthrough results using ADC combination therapies in treatment-resistant patients.
Japan: Recent Industry Developments
✅ In October 2025, Daiichi Sankyo introduced a next-generation ADC platform with enhanced stability and reduced off-target effects.
✅ In October 2025, Japan's Pharmaceuticals and Medical Devices Agency established accelerated review pathways for innovative ADC candidates.
✅ In October 2025, Takeda Pharmaceutical developed a novel linker technology improving ADC payload delivery efficiency by 40%.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/antibody-drug-conjugates-market?jd
Market Trends & Drivers
The Antibody Drug Conjugates Market is experiencing rapid growth driven by advancements in targeted cancer therapy, increasing ADC approvals, and expanding therapeutic applications. Key trends include the development of novel payloads, improved linker technologies, and expansion beyond oncology into autoimmune and infectious diseases. The growing understanding of cancer biology, rising investment in precision medicine, and successful clinical outcomes are significantly accelerating market expansion across therapeutic areas.
Competitive Landscape
The market features strong competition among pharmaceutical innovators, biotechnology companies, and research institutions.
Roche Holding AG leads with its Kadcyla and Polivy ADCs and extensive pipeline development.
AstraZeneca PLC advances its ADC portfolio through strategic collaborations and internal research programs.
Pfizer Inc. maintains a strong position with its ADC technologies and ongoing clinical development.
GSK plc focuses on oncology ADCs with novel mechanisms of action and targeted delivery.
Daiichi Sankyo Company Limited pioneers next-generation ADC platforms with global partnerships.
Seagen Inc. (Pfizer) specializes in ADC technology and targeted cancer therapies.
ImmunoGen Inc. develops proprietary ADC technologies and novel payload systems.
ADC Therapeutics SA focuses on proprietary pyrrolobenzodiazepine-based ADC platforms.
Mersana Therapeutics Inc. advances its Dolaflexin and other ADC platform technologies.
Byondis B.V. develops proprietary ADC technologies with focus on optimized therapeutic windows.
Segmentation
By Product Type (Adcetris, Perjeta, Kadcyla, Enhertu, Padcev, Trodelvy, Polivy, Others)
By Target Type (CD30 Antibodies, HER2 Antibodies, CD22 Antibodies, Others)
By Technology Type (Linker Technology, Payload Technology, Others)
By Application (Breast Cancer, Blood Cancer, Skin Cancer, Lung Cancer, Others)
By End-User (Hospitals, Cancer Centres, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/antibody-drug-conjugates-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
At DataM Intelligence, we provide more than just data-we deliver end-to-end business solutions. From deep-dive research to strategic consulting, we partner with you to turn complex market trends into a clear competitive advantage.
Leveraging our extensive database of 6,300+ reports across 40+ domains, we offer the insights and astute recommendations you need to make confident decisions. We are proud to support 200+ companies worldwide in navigating their key business challenges and accelerating their growth trajectory.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Antibody Drug Conjugates Market to Reach USD 30.42 Billion by 2033, Driven by Targeted Cancer Therapy and Pipeline Expansion | DataM Intelligence here
News-ID: 4237876 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
US Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid G …
The Global Single Cell Omics Market was valued at US$ 2.4 billion in 2022 and is projected to reach US$ 15.5 billion by 2032, growing at a CAGR of 20.2% during the forecast period.The market growth is driven by the rapid advancements in single-cell sequencing technologies, increasing investment in genomics and precision medicine, and growing applications in oncology, immunology, and neurobiology research. The rising need for high-resolution cellular analysis to…
United States Slow Release & Controlled Release Fertilizer Market 2025 | Growth, …
According to DataM Intelligence Comprehensive Report has released its latest report on the "Slow Release and Controlled Release Fertilizers Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves…
United States Metallocene Polyethylene Market 2025: Industry Developments, Futur …
Global Metallocene polyethylene Market is expected to grow at a CAGR of 6.5% during the forecasting period 2024-2031.
According to DataM Intelligence, the Metallocene Polyethylene (mPE) market is experiencing healthy demand growth as converters and brand owners seek higher-performance, downguageable films, improved sealability, and recyclable-friendly resin solutions. mPE's combination of narrow molecular weight distribution, enhanced toughness, puncture resistance and processability makes it a preferred choice for flexible packaging, agriculture films, construction…
US Immune Health Probiotic Supplements Market Growth Forecast 2025-2031: Market …
The Global Immune Health Probiotic Supplements Market was valued at US$ 220.1 million in 2023 and is anticipated to reach US$ 394.6 million by 2031, registering a CAGR of 8.7% during the forecast period (2024-2031). Market expansion is primarily driven by the increasing adoption of preventive healthcare practices, rising awareness regarding immune resilience, and the growing incorporation of probiotic formulations into daily nutrition. Consumers are increasingly seeking clinically validated, microbiome-supportive…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates.
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
